Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. - Wikidata - awgldk - TriplyDB

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

http://www.wikidata.org/entity/Q33248480

about

Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine Vaccines for preventing typhoid fever Vaccines for preventing typhoid fever Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies Vaccination for typhoid fever in sub-Saharan Africa Vaccines against invasive Salmonella disease: current status and future directions Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas Analysis of Salmonella enterica serotype paratyphi A gene expression in the blood of bacteremic patients in Bangladesh Immunology of Gut Mucosal Vaccines Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005.Salmonella paratyphi A rates, Asia.High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia.Adults' perceived prevalence of enteric fever predicts laboratory-validated incidence of typhoid fever in children A study of typhoid fever in five Asian countries: disease burden and implications for controls.Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy.Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi Host adaptation and the emergence of infectious disease: the Salmonella paradigm.Active immunization in the United States: developments over the past decade.Antibiotics modulate vaccine-induced humoral immune response.Enhancement by ampicillin of antibody responses induced by a protein antigen and a DNA vaccine carried by live-attenuated Salmonella enterica serovar Typhi.Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909 Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.Development of Vi conjugate - a new generation of typhoid vaccine.Travel vaccines and elderly persons: review of vaccines available in the United States.Typhoid outbreak in Songkhla, Thailand 2009-2011: clinical outcomes, susceptibility patterns, and reliability of serology tests Updated recommendations for the use of typhoid vaccine--Advisory Committee on Immunization Practices, United States, 2015.Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid.

P2860

Q21245322-56304650-D513-4974-86BF-314F8060D9E3 Q24201238-45586F4F-00B3-4CEE-9CC7-F457595DEDB3 Q24244406-070BB4B2-8D65-44A1-B8B4-B9DEE4ABA2FF Q26773033-6871B2CA-7B10-4666-96D6-F0F542294F73 Q27004049-1999D4CE-4411-430F-995C-AC456C8C6220 Q27007088-775F9900-3750-4AF0-93C4-56A380A4CC0D Q28084595-28B2709F-E75C-4001-A7A9-70A89B871325 Q28307137-C22C00F6-45AC-4906-8519-17C1F03140B3 Q28308143-402F3588-ADF2-4199-9303-C76C82D41811 Q28476453-F1CD0856-F207-41BA-A635-81D10BCFD9C6 Q28972559-3F6C4ECB-DBC3-4C70-A10B-D4FA932F75F3 Q31121277-A5B151EA-0E41-44C2-808B-3562E55D9F1E Q33228201-CF8B1B57-F091-441A-9D18-C5D9467649FD Q33322647-341CD79A-C7E3-4A7B-BEA1-3A7B06F30790 Q33327527-AB688067-561A-4B55-A073-AAE62CDB4874 Q33330938-056CC6C4-DAC2-45CE-BE69-8313503979BE Q33593401-013E8B27-1AEE-4C20-B15B-199FEF0BF4D7 Q33690625-5F85B192-14CA-43A3-832F-674AB3892A83 Q33763029-709DFF93-3496-4980-81D7-BBFE2E3C2184 Q33910337-4360B754-760E-4BC1-BE09-977F1DF0B512 Q33938210-7B5C7ECF-5FAF-45E8-B71F-67A607A9BB50 Q33975799-D9E7AF93-385B-460C-87F5-E042958770F6 Q33997972-4304AACD-1C07-4ED2-9E29-0886E7CC96C3 Q33998484-566684AE-F2E0-4AA0-9AD9-73834F804460 Q34002415-ABF9E5DA-1645-428F-BADC-9595EA0B3A8A Q34003647-D2113523-2CBE-4E34-BF09-D94CAFB3115D Q34007802-82946933-B7DB-4D17-B3DD-239A14A7B37E Q34008449-5B477EB4-F33E-4618-9FFE-F9B6655B092E Q34070619-FE78C4EE-5C88-4EC3-B8EA-F813BBFDFE4C Q34380025-763BE822-30DD-4752-AEDA-584E98241831 Q34392982-D8D47284-5196-42B8-B633-E18080A69057 Q34465875-23D60A3F-2FAF-4A3E-B770-8E2FFD2114ED Q34468771-AC2CFBF0-BDE7-4355-9D18-A8C553816ACF Q34528102-A05B80D4-C622-4CD9-ABCD-CC5E6D84A50A Q34541176-B9742546-1DBA-49BA-A4D5-1A26E83DDDD9 Q35399988-74891B00-B3E0-4D14-BDDD-8440DD56ED18 Q35485187-A7F727C3-1332-43E0-B7A2-257BA6CB2B03 Q35505761-4CDE3CF0-587D-4413-998E-14448A3679D5 Q35689430-A0C58A4F-6C55-4BD4-90C7-D5B66E4D8D08 Q35824212-7CA1310C-07B7-44C5-A4BE-364CF2EE18E3

P2860

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

http://www.wikidata.org/entity/Q33248480

description

1991 nî lūn-bûn

@nan

1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@ast

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@en

type

label

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@ast

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@en

prefLabel

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@ast

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@en

P1433

Q33248480-94DD5AAE-260D-42CB-80EA-B025FEA217C2

P1476

Q33248480-ACE68B0F-5028-4094-8DA0-9322D2FD1AC5

P2093

Q33248480-3D248E97-D35F-44F5-B14C-4F914F9846CF

Q33248480-530E4F92-CD47-445D-930B-8C8D57770DC7

Q33248480-728BA224-515D-4775-8AA5-1C9AECA08191

Q33248480-7C278871-EF67-4BF5-AF5F-4C093D836F82

Q33248480-A3DCD28A-F99D-4B1D-8D41-442FC5D6184F

Q33248480-AE4763A4-C06A-43E8-8C58-1211711D0D4D

Q33248480-C56C61A4-B09E-45F1-90FC-AA7B3B9249EE

Q33248480-DE28C8D7-45B5-48E6-8108-26E31D2747C1

Q33248480-E31D649F-CC20-4F2A-A46B-11BF6E13C6B1

Q33248480-F821DC50-8AE4-4652-A5AC-23EA19D01ACC

P304

Q33248480-E39AC3EF-8812-4EB5-BF59-E523E7B092B5

P31

Q33248480-97882637-78E0-431F-9C97-3DDD2FECEE1D

P356

Q33248480-5018D5F7-AAB4-4AB6-B2C1-652ED7547209

P407

Q33248480-0A8D5956-7305-4B5D-80EE-03815090F146

P433

Q33248480-71551CCC-D530-408B-90AD-21355368363C

P478

Q33248480-88451964-C34E-49B0-95D0-9381F1421297

P577

Q33248480-F6903775-2B60-4503-8BBA-74E53212D019

P698

Q33248480-7A9CC844-61E9-44F9-88D8-40A313FF7941

P921

Q33248480-B55BA9AE-7BC6-46D7-BE28-2872802FFD83

P356

0140-6736(91)91910-M

P1433

P1476

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

@en

P2093

C H Simanjuntak

http://www.w3.org/2001/XMLSchema#string

E Suprijanto

http://www.w3.org/2001/XMLSchema#string

F P Paleologo

http://www.w3.org/2001/XMLSchema#string

H Totosudirjo

http://www.w3.org/2001/XMLSchema#string

N D Witham

http://www.w3.org/2001/XMLSchema#string

N H Punjabi

http://www.w3.org/2001/XMLSchema#string

P Haryanto

http://www.w3.org/2001/XMLSchema#string

R Darmowigoto

http://www.w3.org/2001/XMLSchema#string

S L Hoffman

http://www.w3.org/2001/XMLSchema#string

Soeprawoto

http://www.w3.org/2001/XMLSchema#string

P304

1055-1059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0140-6736(91)91910-M

http://www.w3.org/2001/XMLSchema#string

P407

P433

8774

http://www.w3.org/2001/XMLSchema#string

P478

338

http://www.w3.org/2001/XMLSchema#string

P577

1991-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1681365

http://www.w3.org/2001/XMLSchema#string

P921